Novavax Shares Surge 17% After Surprise Q4 Profit and Revenue Beat

Novavax (NVAX) shares experienced a significant rally, jumping 17% following the release of its robust fourth-quarter financial results. The biotechnology company reported a surprise profit, defying analyst expectations and signaling a strong operational turnaround. Total revenue for the quarter soared by 67% year-over-year, primarily driven by robust licensing revenues. In addition to top-line growth, the company successfully implemented cost-reduction strategies that significantly lowered operating expenses. This combination of higher income and disciplined spending facilitated the company's swing to profitability during the period. Investors reacted positively to the improved financial health, driving renewed confidence in the company's long-term trajectory within the biotech sector.